
    
      This study will evaluate the long-term efficacy of oral aripiprazole in the treatment of
      pediatric participants with Tourette's Disorder (TD). The trial consists of 3 distinct
      phases: a pretreatment phase, open-label stabilization phase, and a double-blind randomized
      withdrawal phase.
    
  